These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18024650)

  • 1. Biology and treatment of primary myelofibrosis.
    Hoffman R; Rondelli D
    Hematology Am Soc Hematol Educ Program; 2007; ():346-54. PubMed ID: 18024650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the understanding and management of primary myelofibrosis.
    Cervantes F; Pereira A
    Curr Opin Oncol; 2011 Nov; 23(6):665-71. PubMed ID: 21892083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New and old treatment modalities in primary myelofibrosis.
    Cervantes F; Mesa R; Barosi G
    Cancer J; 2007; 13(6):377-83. PubMed ID: 18032975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing between stem cell therapy and drugs in myelofibrosis.
    Kröger N; Mesa RA
    Leukemia; 2008 Mar; 22(3):474-86. PubMed ID: 18185525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia.
    Hogan WJ; Litzow MR; Tefferi A
    Curr Hematol Malig Rep; 2007 Feb; 2(1):34-42. PubMed ID: 20425386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment with reduced-intensity stem cell transplantation for primary myelofibrosis].
    Ito S; Hagihara M; Motohashi K; Maruta A; Ishigatsubo Y; Gomi S; Kanamori H
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):351-3. PubMed ID: 20154501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Challenges in Stem Cell Transplantation in Myelofibrosis.
    Kröger N
    Curr Hematol Malig Rep; 2015 Dec; 10(4):344-50. PubMed ID: 26285891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational therapeutic options for patients with myeloproliferative neoplasms.
    Hoffman R
    Trans Am Clin Climatol Assoc; 2011; 122():11-26. PubMed ID: 21686205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are we altering the natural history of primary myelofibrosis?
    Savona MR
    Leuk Res; 2014 Sep; 38(9):1004-12. PubMed ID: 24931396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation as treatment for myelofibrosis.
    Papageorgiou SG; Castleton A; Bloor A; Kottaridis PD
    Bone Marrow Transplant; 2006 Dec; 38(11):721-7. PubMed ID: 17013423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Expression Pattern in Bone Marrow Microenvironment after Allogeneic Stem Cell Transplantation in Primary Myelofibrosis.
    Hussein K; Stucki-Koch A; Alchalby H; Triviai I; Kröger N; Kreipe H
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):644-650. PubMed ID: 26708839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for myelofibrosis.
    van Besien K; Deeg HJ
    Semin Oncol; 2005 Aug; 32(4):414-21. PubMed ID: 16202687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in young patients with intermediate- / high-risk myelofibrosis: estimates derived from databases for non transplant patients.
    Siragusa S; Passamonti F; Cervantes F; Tefferi A
    Am J Hematol; 2009 Mar; 84(3):140-3. PubMed ID: 19123461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for patients with myelofibrosis in blast phase.
    Mascarenhas J; Navada S; Malone A; Rodriguez A; Najfeld V; Hoffman R
    Leuk Res; 2010 Sep; 34(9):1246-9. PubMed ID: 20627294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stem cell transplantation in myelofibrosis].
    Toivari A; Itälä-Remes M; Kauppila M; Putkonen M; Salmenniemi U; Remes K
    Duodecim; 2011; 127(22):2375-82. PubMed ID: 22238916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens.
    Merup M; Lazarevic V; Nahi H; Andreasson B; Malm C; Nilsson L; Brune M; LeBlanc K; Kutti J; Birgegård G;
    Br J Haematol; 2006 Nov; 135(3):367-73. PubMed ID: 16972981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic myelofibrosis.
    Barosi G; Hoffman R
    Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic cord hematopoietic stem cell transplantation in an infant with primary myelofibrosis.
    Shaikh F; Naithani R; Kirby-Allen M; Doyle J
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):e199-201. PubMed ID: 22246154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.